There are concerns about withdrawal of stimulus measures, but US investors are unconcerned for now.
Investors have for the moment reverted to the glass half-full mentality, with buying interest in big tech propelling the Nasdaq to a record closing high.
Sentiment was also buoyed by the US Food and Drug Administration granting full approval for the Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) Covid-19 vaccine, prompting hopes that the level of inoculations could be accelerated as a result. The Delta variant has become a drag on economic recovery generally and measures to mitigate its impact will have positive effects.
Indeed, a third monthly drop in business activity in the US showed the effects which the variant is having, although more positive news came in the form of a rise in home sales. Economic data continues to be mixed, potentially lessening the pressure on the Federal Reserve to instigate its tapering plan, with no overheating in evidence. The Jackson Hole symposium - an annual meeting of central bankers, policymakers, academics and economists in Wyoming - which begins on Thursday, remains the next focus of attention for further colour.
The reversion to a risk-on approach from investors nudged the major indices higher and in the year to date the Dow Jones has now added 15.5%, the S&P500 19.3% and the Nasdaq 15.9%.
- The warning signs that a market crash is about to happen
- Want to buy and sell international shares? It’s easy to do. Here’s how
The generally improved sentiment on the economic outlook was positive for the recently beleaguered oil price, and commodities in general.
This fed through to a positive showing from the FTSE100, although the more domestically focused FTSE250 dipped slightly on some ongoing pressure for the UK economy. Investors will be looking out for signs that blockages in the supply chain are being cleared and that the current levels of labour shortages can be reversed, neither of which are currently in evidence.
Despite a positive showing from Asian markets overnight, stocks exposed to the region remain under pressure, with the likes of Burberry Group (LSE:BRBY) slipping slightly once more and now down by 11% over the last month. More positively, cyclical stocks including commodities are among the early risers within the premier index.
The UK markets may be attracting further international investor interest on valuation grounds and prospects for a broad return to economic growth, and in the year to date the FTSE100 is ahead by 10.2% and the FTSE250 by 16.3%.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.